PsiOxus Therapeutics Appoints Melissa Epperly as Chief Financial Officer
June 04, 2018 03:00 ET
|
PsiOxus Therapeutics, Ltd.
PHILADELPHIA and OXFORD, United Kingdom, June 04, 2018 (GLOBE NEWSWIRE) -- PsiOxus Therapeutics, Ltd. (PsiOxus), a leader in gene therapy for cancer, today announced the appointment of Melissa...
PsiOxus Therapeutics Receives $15 Million Milestone Payment as Armed Oncolytic Virus Licensed to Bristol-Myers Squibb Achieves CTA
December 12, 2017 03:00 ET
|
PsiOxus Therapeutics, Ltd.
OXFORD, United Kingdom, Dec. 12, 2017 (GLOBE NEWSWIRE) -- PsiOxus Therapeutics, Ltd. (PsiOxus) today announced that the Clinical Trial Application for NG-348, an “armed” oncolytic virus for the...